Blood cancer atlas: 1,000-Patient study hopes to personalize treatment

NCT ID NCT07445438

Recruiting now Knowledge-focused Sponsor: Azienda Ospedaliero-Universitaria di Parma Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is collecting bone marrow, blood, and tissue samples from over 1,000 people with various blood cancers. Researchers will use advanced genetic and protein analysis to identify unique markers for each cancer type. They will also test cancer cells against a library of 300 drugs to see which ones work best. The goal is to build a national platform that could one day help doctors choose more personalized treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better classify blood cancers and choose more effective drugs for each patient.
What could go wrong: This is an early, observational study focused on feasibility. It does not test a treatment, so direct patient benefits are uncertain and may take years to realize.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute leukemia chronic leukemia lymphoproliferative syndrome myelodysplastic syndrome Myeloproliferative Disorders myeloproliferative neoplasm plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE LEUKEMIA CHRONIC LEUKEMIA LYMPHOPROLIFERATIVE DISORDERS MYELODYSPLASTIC DISORDERS MYELOMA MULTIPLE MYELOPROLIFERATIVE DISORDERS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Parma
RECRUITING

Parma, PR, 43126, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.